当前位置: 首页 > 期刊 > 《中国现代医生》 > 2019年第18期
编号:13369822
成骨不全症合并骨折应用3D打印技术辅助内固定1例报告(3)
http://www.100md.com 2019年6月25日 《中国现代医生》 2019年第18期
     [11] Jain M,Tam A,Shapiro JR,et al. Growth characteristics in individuals with osteogenesis imperfecta in North America:Results from a multicenter study[J]. Genet Med,2019,21(2):275-283.

    [12] Li Y,Xuan M,Wang B,et al. Comparison of parathyroid hormone(1-34) and elcatonin in postmenopausal women with osteoporosis:An 18-month randomized,multicenter controlled trial in China[J]. Chin Med J (Engl),2013, 126(3):457-463.

    [13] Rotman M,Hamdy N,Appelman-Dijkstra NM. Clinical and translational pharmacological aspects of the management of fibrous dysplasia of bone[J]. Br J Clin Pharmacol,2018, 14(6):256-267.

    [14] Biggin A,Munns CF. Long-term bisphosphonate therapy in osteogenesis imperfecta[J]. Curr Osteoporos Rep,2017, 15(5):412-418.

    [15] 雒瑤,朱宝生. 成骨发育不全研究进展[J]. 中国妇幼保健,2017,32(6):1333-1336.

    [16] Kuurila K,Pynnonen S,Grenman R. Stapes surgery in osteogenesis imperfecta in Finland[J]. Ann Otol Rhinol Laryngol,2004,113(3 Pt 1):187-193.

    [17] Birke O,Davies N,Latimer M,et al. Experience with the Fassier-Duval telescopic rod:First 24 consecutive cases with a minimum of 1-year follow-up[J]. J Pediatr Orthop, 2011,31(4):458-464.

    [18] 张稳,黄加强,夏红. 3D打印技术在复杂骨折手术治疗中的应用价值[J]. 中国医师杂志,2017,19(3):479.

    (收稿日期:2019-03-26), http://www.100md.com(王园 徐生林 阙玉康 胡勇)
上一页1 2 3